NCT05156151 (Relex-Smile) is a NA clinical trial of Relex-Smile in Stromal Keratitis, sponsored by Eye Hospital Pristina Kosovo.

Who is sponsoring NCT05156151?

NCT05156151 is sponsored by Eye Hospital Pristina Kosovo.

What drugs are being tested in NCT05156151?

Interventions in NCT05156151: Relex-Smile.

What condition does NCT05156151 study?

NCT05156151 studies Stromal Keratitis.

Is NCT05156151 still recruiting?

NCT05156151 is currently status unknown. Last updated 20 February 2024.

Last reviewed 2024-02-20 · How we verify

NCT05156151: Relex-Smile

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stromal Lenticule Implantation for Management of Herpetic Stromal Keratitis

Status unknown NA Last updated 20 February 2024

What this trial tests

NA trial testing Relex-Smile in Stromal Keratitis in 35 participants. Status unknown.

Timeline

1 January 2017

Primary endpoint
1 January 2020

1 January 2025

Quick facts

Lead sponsor	Eye Hospital Pristina Kosovo
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	35
Start date	1 January 2017
Primary completion	1 January 2020
Estimated completion	1 January 2025
Sites	1 location across Kosovo

Drugs / interventions tested

Relex-Smile

Conditions studied

Stromal Keratitis — all drugs for Stromal Keratitis →

Sponsor

Eye Hospital Pristina Kosovo

Who can join

Adults 21 to 46, any sex, with Stromal Keratitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is the evaluation of corneal transparency and improvement of visual acuity in patients with herpetic stromal keratitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Eye Hospital Pristina Kosovo trials

Trials by the same sponsor.

NCT04642729 — Fresh Corneal Lenticule Implantation in Macular Corneal Distrophy With Relex Smile Surgery · NA · unknown
NCT04594512 — Fresh Corneal Lenticule Implantation and Autologous Serum - Case Report · NA · active not recruiting
NCT04616144 — Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism · NA · active not recruiting
NCT04793893 — Treatment of Residual Hypermetropic Refraction on Young Patients After LASIK Using Human Fresh Corneal Lenticule Implant · NA · unknown
NCT04468022 — Toric Trifocal IOL Treatment With High Astigmatism and Hyperopia vs SMILE Enhancement After Trifocal IOL Treatment · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05156151 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eye Hospital Pristina Kosovo
Last refreshed: 20 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05156151.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing